Intensive Pre-Stem Cell Transplant Regimen May be Best for Younger Patients with AML, MDS

Results from a large phase III clinical trial suggest that a highly intensive preparatory regimen should be used for younger patients with acute myeloid leukemia or myelodysplastic syndromes preparing to undergo an allogeneic stem cell transplant.


Cancer Currents: An NCI Cancer Research Blog

Comments